Good news for stem cell patents in German Brüstle ruling
03 December 2012
|
Emma Barraclough, London
One year after the Court of Justice of the EU limited the stem cell research that can be protected by patents in Brüstle, the German Federal Court has ruled in the original case
In October 2011, Europe's highest court decided that a process that involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented.
It was ruling in a case...
Please
log in to read the rest of this article.
New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Already registered?
Please make sure you log in to read the rest of the article.
Log in
Join us now
Gain FREE access to up to five free articles when you register now. Join here